Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery

NCT03048578 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Saxenda
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]